Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol
Robert Galen
American Journal of Obstetrics and Gynecology, 2007
View PDFchevron_right
Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women
Karin Sundberg
Ultrasound in Obstetrics and Gynecology, 2005
View PDFchevron_right
Review article Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions
Peter Benn
2002
View PDFchevron_right
A prospective two years study of first trimester screening for Down syndrome
A. Daniilidis
Hippokratia, 2008
View PDFchevron_right
Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions
Peter Benn
2002
View PDFchevron_right
Second Trimester Antenatal Screening for Down’s Syndrome
Guido Vranken
View PDFchevron_right
A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol
Gail Prins
American Journal of Obstetrics and Gynecology, 1993
View PDFchevron_right
Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing
Peter Benn
Clinica Chimica Acta, 2002
View PDFchevron_right
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study
Isabelle Czerkiewicz
American Journal of Obstetrics and Gynecology, 2013
View PDFchevron_right
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1996
View PDFchevron_right
Maternal serum screening for Down's syndrome in early pregnancy
James Densem
BMJ, 1988
View PDFchevron_right
Maternal serum screening for Down's syndrome in the first trimester of pregnancy
Ettore Cariati
BJOG: An International Journal of Obstetrics and Gynaecology, 1995
View PDFchevron_right
Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories
Peter Benn
Clinical chemistry, 2006
View PDFchevron_right
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha- fetoprotein and unconjugated oestriol
Bernadette Mermillod
Human Reproduction, 1998
View PDFchevron_right
First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10–14 weeks of gestation
Johan Schiettecatte
Fertility and Sterility, 2008
View PDFchevron_right
Combining first and second trimester markers for Down syndrome screening: Think twice
Kate Brameld
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2008
View PDFchevron_right
Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population
L. Bidat, Isabele Durand-zaleski
American Journal of Obstetrics and Gynecology, 2006
View PDFchevron_right
A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome
Françoise Muller
Prenatal Diagnosis, 1990
View PDFchevron_right
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Mary D'Alton
New England Journal of Medicine, 2005
View PDFchevron_right
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies Commentary: Results may not be widely applicable Authors' response
Stuart Logan
BMJ, 2001
View PDFchevron_right
Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures
Geralyn Messerlian
Prenatal Diagnosis, 2015
View PDFchevron_right
Evaluation of First Trimester Contingent Test for Down ’ S Syndrome Screening
Kusagradhi Ghosh
Journal of Evolution of medical and Dental Sciences, 2015
View PDFchevron_right
First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study
Kevin Spencer
Prenatal Diagnosis, 2007
View PDFchevron_right
Maternal serum markers in screening for Down syndrome
Ann Tabor
Clinical Genetics, 2008
View PDFchevron_right
Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters
sujatha jagadeesh
The Journal of Obstetrics and Gynecology of India
View PDFchevron_right
α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome
John Owen
American Journal of Obstetrics and Gynecology, 1997
View PDFchevron_right
Antenatal screening for Down's syndrome in assisted reproductive pregnancies
Eli Dreazen
Human Reproduction Update, 1999
View PDFchevron_right
Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland
Yrtti Valinen
American Journal of Obstetrics and Gynecology, 2007
View PDFchevron_right
Down syndrome screening marker levels in women with a previous aneuploidy pregnancy
Kevin Spencer
Prenatal Diagnosis, 2005
View PDFchevron_right
P07.01: Patient's perception of first trimester risk assessment for Down syndrome: what is a “high risk” for you?
Noirin Russell
Ultrasound in Obstetrics & Gynecology
View PDFchevron_right
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays
Kevin Spencer
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005
View PDFchevron_right
Comparison of First Trimester Screening for Down's Syndrome Using Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A Levels between Spontaneous and IVF Pregnancies at 12 Weeks of Gestation
Marzieh Zamaniyan, international journal of fertility and sterility Int J Fertil Steril
Volume 13, Number 2, Jul-Sep 2019 Pages: 93-96, 2019
View PDFchevron_right
A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study
Martin Weinans
Prenatal Diagnosis, 2004
View PDFchevron_right
New Developments in Prenatal Screening for Down Syndrome
Robert Mooney
Pathology Patterns Reviews, 2003
View PDFchevron_right
Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies
OMKAR SINGH
American Journal of Obstetrics and Gynecology, 2000
View PDFchevron_right